JP2023500834A5 - - Google Patents

Info

Publication number
JP2023500834A5
JP2023500834A5 JP2022525241A JP2022525241A JP2023500834A5 JP 2023500834 A5 JP2023500834 A5 JP 2023500834A5 JP 2022525241 A JP2022525241 A JP 2022525241A JP 2022525241 A JP2022525241 A JP 2022525241A JP 2023500834 A5 JP2023500834 A5 JP 2023500834A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
groups
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2022525241A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023500834A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/057875 external-priority patent/WO2021087056A1/en
Publication of JP2023500834A publication Critical patent/JP2023500834A/ja
Publication of JP2023500834A5 publication Critical patent/JP2023500834A5/ja
Withdrawn legal-status Critical Current

Links

JP2022525241A 2019-10-30 2020-10-29 免疫調整剤 Withdrawn JP2023500834A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962927739P 2019-10-30 2019-10-30
US62/927,739 2019-10-30
US201962930654P 2019-11-05 2019-11-05
US62/930,654 2019-11-05
US201962931995P 2019-11-07 2019-11-07
US62/931,995 2019-11-07
PCT/US2020/057875 WO2021087056A1 (en) 2019-10-30 2020-10-29 Immunomodulators

Publications (2)

Publication Number Publication Date
JP2023500834A JP2023500834A (ja) 2023-01-11
JP2023500834A5 true JP2023500834A5 (https=) 2023-11-07

Family

ID=73544318

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022525241A Withdrawn JP2023500834A (ja) 2019-10-30 2020-10-29 免疫調整剤

Country Status (6)

Country Link
US (1) US20220389061A1 (https=)
EP (1) EP4051692A1 (https=)
JP (1) JP2023500834A (https=)
KR (1) KR20220088868A (https=)
CN (1) CN114555627A (https=)
WO (1) WO2021087056A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4087857B1 (en) 2020-01-06 2023-11-01 Bristol-Myers Squibb Company Immunomodulators
KR20220161407A (ko) 2020-03-30 2022-12-06 브리스톨-마이어스 스큅 컴퍼니 면역조정제
CN116322735A (zh) * 2020-10-02 2023-06-23 百时美施贵宝公司 大环肽硼酸盐免疫调节剂

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US5374548A (en) 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
MX9203291A (es) 1985-06-26 1992-08-01 Liposome Co Inc Metodo para acoplamiento de liposomas.
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5108921A (en) 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
WO2007076055A2 (en) * 2005-12-22 2007-07-05 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
US9308236B2 (en) 2013-03-15 2016-04-12 Bristol-Myers Squibb Company Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
WO2016039749A1 (en) * 2014-09-11 2016-03-17 Bristol-Myers Squibb Company Macrocyclic inhibitors of the pd-1/pd-l1 and cd80 (b7-1)/pd-li protein/protein interactions
KR102526034B1 (ko) * 2016-11-07 2023-04-25 브리스톨-마이어스 스큅 컴퍼니 면역조정제
KR20220010535A (ko) * 2019-05-21 2022-01-25 브리스톨-마이어스 스큅 컴퍼니 면역조정제

Similar Documents

Publication Publication Date Title
JP2023510737A5 (https=)
JP2023510736A5 (https=)
JP2023503050A5 (https=)
JP2023500834A5 (https=)
JP2016503414A5 (https=)
JP2024516997A5 (https=)
RU2015118647A (ru) Аминопиримидиновые соединения в качестве ингибиторов содержащих т790м мутантных egfr
JP2021063120A5 (https=)
JP2020515574A5 (https=)
JP2014510727A5 (https=)
RU2018128334A (ru) Ингибиторы индоламин-2,3-диоксигеназы (ido)
JP2020525429A5 (https=)
JP2013539795A5 (https=)
JP2019512478A5 (https=)
JP2007534695A5 (https=)
RU2015126856A (ru) Дисульфидные маскированные пролекарственные композиции и способы
CA2736177A1 (en) Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases
JP2016519062A5 (https=)
JP2011509949A5 (https=)
JP2015504076A5 (https=)
IL292193B1 (en) Anti-b7-h1 antibodies for treating tumors
JP2017536344A5 (https=)
RU2014125230A (ru) Пиридонамиды и их аналоги, демонстрирующие противораковую и антипролиферативную активность
CN107548391A (zh) 嘧啶或吡啶类化合物、其制备方法和医药用途
TR201809990T4 (en) NEW COMPOSITIONS, USES AND METHODS FOR THEIR MAKING.